Patent Baristas

The U.S. Court of Appeals for the Federal Circuit looked at the issue of whether Aventis committed that most horrible of patent sins — inequitable conduct before the United States Patent and Trademark Office (PTO).   Aventis Pharma v. Amphastar and Teva (07-1280) . Earlier, the CAFC held that the dosage of the prior art composition […]

Please join Governor Steven L. Beshear for a celebration of Kentucky’s biotechnology sector at the BIO 2008 International Convention next week. Governor Beshear is hosting the Commonwealth of Kentucky Reception on Thursday, June 19, from 5:00 until 7:00 P.M. at the Marriott Hotel & Marina, Coronado Terrace, 4th Floor South Tower (333 West Harbor Drive, […]

The Baristas rock and now you can, too! Editor-in-Chief Barista, Stephen Albainy-Jenei, will be giving away some iPod Shuffles at the 2008 BIO International Convention, June 17-20, 2008 at the San Diego Convention Center in San Diego, Calif. Basically, all you have to do to win is be the first person to find me on […]

The Alliance of Minority Medical Associations (AMMA) and the Benenson Strategy Group held a national media briefing on poll results examining health care access and affordability in the US today. Dr. Randall Maxey, M.D., said that polling data show that most voters are unhappy with Washington and they are looking for change.  While Iraq and […]

Rolf Claessen of IP Newsflash fame as well as patent attorney and partner with the patent law firm v. Kreisler Selting Werner in Cologne, Germany, brings us the new Free Patent PDF Download tool.  It’s free. It’s easy to use. It has broad coverage (espacenet database). My only small peeve is that you need to […]

Dan Harris, over at the China Law Blog,  has posted this week’s Blawg Review #162.  This week’s review brings us world peace or at least attempts to enlighten the legal world about China and enlighten China readers about the legal world. It is interesting to learn that after Beijing’s request that its citizens dispense with […]

Before 2017, drug companies will suffer patent losses of $140 billion. Reuters, May 1, 2007 Now is the time for pharmaceutical companies – both brand name and generic – to rethink patent strategies not only in terms of this impending economic reality, but also in terms of the dramatic changes to the patent landscape on […]

The Connecticut Attorney General is suing McKesson Corp., the nation’s largest pharmaceutical distributor, on allegations it illegally inflated wholesale drug costs for many brand-name drugs, including Lipitor and Prevacid. Genzyme Corp. spent $640,000 lobbying the federal government in the first quarter on matters such as on patent-reform legislation and bills that would allow generic drug […]